1. Vargas JC, Marques MO, Pereira J, Braga WMT, et al.
   Factors associated with survival in patients with lymphoma and HIV: the largest cohort study in Brazil.
   AIDS 2023.
   


2. Oomen PGA, Bronsveld I, Hoepelman AIM, van Welzen BJ, et al.
   No long-term effect of past Pneumocystis jirovecii pneumonia on pulmonary function in people with HIV.
   AIDS 2023.
   


3. Rodriguez VJ, Alfonso D, VanLandingham H, Kozlova S, et al.
   Prevalence of neurodevelopmental delays in infants with perinatal HIV infection in comparison with HIV exposure in rural South Africa.
   AIDS 2023.
   


4. Izquierdo Miguel R, Rava M, Moreno-Garcia E, Blanco JR, et al.
   HIV medical care interruption among people living with HIV in Spain, 2004-2020.
   AIDS 2023.
   


5. Wilck M, Barnabas S, Chokephaibulkit K, Violari A, et al.
   A phase 3 study of safety and immunogenicity of V114, a 15-valent PCV, followed by PPSV23, in children living with HIV.
   AIDS 2023.
   


6. Li Z, Kang Q, Liu Y, Jia L, et al.
   Identification of two Novel HIV-1 Second-generation Recombinant Forms (CRF01_AE/CRF07_BC) in Men Who Have Sex with Men in Hebei, China.
   AIDS Res Hum Retroviruses 2023.
   


7. Bahr NC, Skipper CP, Huppler-Hullsiek K, Ssebambulidde K, et al.
   Recurrence of symptoms following cryptococcal meningitis - characterizing a diagnostic conundrum with multiple etiologies.
   Clin Infect Dis 2022.
   


8. Harris E.
   First HIV Remission in Patient Treated With Stem Cells From Cord Blood.
   JAMA 2023.
   


9. Kavishe BB, PrayGod G, Brage S, Kitilya BW, et al.
   Changes in nocturnal heart rate variability in people living with HIV during the first year of antiretroviral therapy compared to HIV-uninfected community controls.
   J Acquir Immune Defic Syndr 2023.
   


10. Thorman J, Bjorkman P, Sasinovich S, Tesfaye F, et al.
    Performance of Galectin-9 for identification of HIV viremia in adults receiving antiretroviral therapy in a resource-limited setting.
    J Acquir Immune Defic Syndr 2023.
    


11. Gaitan NC, D'Antoni ML, Acosta RK, Gianella S, et al.
    Comparative analysis of pre-existing HIV drug resistance mutations in proviral DNA via Next-Generation Sequencing and routine HIV RNA genotyping.
    J Acquir Immune Defic Syndr 2023.
    


12. Bundgard J, Reimer Jensen AM, Suarez-Zdunek MA, Hogh J, et al.
    Peripheral artery disease and markers of endothelial dysfunction and platelet activation in people with HIV.
    J Acquir Immune Defic Syndr 2023.
    


13. Mugo C, Zubayr B, Ezeokafor N, Oyawola B, et al.
    Effect of Dolutegravir and multi-month dispensing on viral suppression among children with HIV.
    J Acquir Immune Defic Syndr 2023.
    


14. Song S, Satta S, Sharma MB, Hugo C, et al.
    Mitoquinone Mesylate and Mitochondrial DNA in End Organs in Humanized Mouse Model of Chronic Treated Human Immunodeficiency Virus Infection.
    J Infect Dis 2023.
    


15. Smith CL, Bednarchik B, Aung H, Wilk DJ, et al.
    Humoral and Cellular Immunity Induced by Adjuvanted and Standard Trivalent Influenza Vaccine in Older Nursing Home Residents.
    J Infect Dis 2023.
    


16. Aden D, Zaheer S, Kumar R, Ranga S, et al.
    Monkeypox (Mpox) outbreak during COVID-19 pandemic - Past and the future.
    J Med Virol 2023.
    


17. Gnanaprakasam R, Keller M, Glassman R, El-Khoury M, et al.
    Mpox in the New York Metropolitan area, Summer 2022.
    J Med Virol 2023.
    


18. Watts G.
    Bern-Thomas Nyang'wa: getting things done in TB and HIV.
    Lancet 2023.
    


19. Nunez I, Valdes-Ferrer SI.
    Fulminant mpox as an AIDS-defining condition: useful or stigmatising?
    Lancet 2023;401:881-884.
    


20. .
    The Fauci Phenomenon, Part 2.
    N Engl J Med 2023;388:e40.
    

Display articles in

• Abstract format
• Medline format